Medicine prices surge in Iran amid US sanctions and blockade

Source Summary

Medication prices are rising sharply in Iran and some treatments have become scarce as US sanctions and a blockade strain the country's pharmaceutical sector. Patients and families are facing difficulties accessing medicines amid the economic pressure on Iran's drug industry.

Why it matters

US sanctions and blockades directly restrict Iran's access to pharmaceuticals and foreign currency, creating a public-health crisis that affects millions of patients dependent on medication.